Literature DB >> 22259643

Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists.

Jennifer M Kaplan1, Basilia Zingarelli.   

Abstract

Entities:  

Year:  2011        PMID： 22259643      PMCID： PMC3258510          DOI： 10.2174/1875041901104010120

Source DB:  PubMed          Journal:  Open Inflamm J


× No keyword cloud information.
  57 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.

Authors:  Franz Meisner; Daniel Walcher; Florence Gizard; Xaver Kapfer; Roman Huber; Anja Noak; Ludger Sunder-Plassmann; Helga Bach; Cornelia Haug; Max Bachem; Tatjana Stojakovic; Winfried März; Vinzenz Hombach; Wolfgang Koenig; Bart Staels; Nikolaus Marx
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-12       Impact factor: 8.311

3.  Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.

Authors:  M Adams; M J Reginato; D Shao; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

4.  Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.

Authors:  V Pasceri; H D Wu; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

5.  Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.

Authors:  H S Camp; S R Tafuri
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

6.  Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis.

Authors:  Mathias Soller; Anja Tautenhahn; Bernhard Brüne; Kai Zacharowski; Stefan John; Hartmut Link; Andreas von Knethen
Journal:  J Leukoc Biol       Date:  2006-01       Impact factor: 4.962

7.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

Authors:  S A Kliewer; B M Forman; B Blumberg; E S Ong; U Borgmeyer; D J Mangelsdorf; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin.

Authors:  Marika Collin; Nimesh S A Patel; Laura Dugo; Christoph Thiemermann
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

9.  Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.

Authors:  Kelly Guyton; Basilia Zingarelli; Sarah Ashton; Giuseppi Teti; George Tempel; Chris Reilly; Gary Gilkeson; Perry Halushka; James Cook
Journal:  Shock       Date:  2003-07       Impact factor: 3.454

10.  Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.

Authors:  Jennifer Kaplan; James A Cook; Michael O'Connor; Basilia Zingarelli
Journal:  Shock       Date:  2007-12       Impact factor: 3.454
View more
  6 in total

1.  Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Authors:  Jennifer Kaplan; Marchele Nowell; Ranjit Chima; Basilia Zingarelli
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

2.  PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis.

Authors:  Ana Elisa Ferreira; Flavia Sisti; Fabiane Sônego; Suojuan Wang; Luciano Ribeiro Filgueiras; Stephanie Brandt; Ana Paula Moreira Serezani; Hong Du; Fernando Q Cunha; Jose Carlos Alves-Filho; Carlos Henrique Serezani
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

Review 3.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

4.  PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

Authors:  Asoka Banno; Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  Nucl Receptor Res       Date:  2017-12-11

5.  Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan.

Authors:  Ming-Shun Hsieh; Sung-Yuan Hu; Shu-Hui Liao; Chia-Ming Chang; Vivian Chia-Rong Hsieh; Chorng-Kuang How
Journal:  Emerg Med Int       Date:  2021-07-23       Impact factor: 1.112

Review 6.  PPARγ in Bacterial Infections: A Friend or Foe?

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  PPAR Res       Date:  2016-09-28       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.